| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |